The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
Clinical trial NCT05339204 · UNKNOWN
Trial details
- NCT number
- NCT05339204
- Sponsor
- National Research Center for Hematology, Russia
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.